Ocular Application of the Kinin B1 Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats
Mylène Pouliot(Université de Montréal), Réjean Couture(Université de Montréal), Sébastien Talbot(Queen's University), Florence Dotigny(Université de Montréal), Elvire Vaucher(Université de Montréal), Jacques Sénécal(Université de Montréal)
Cited by 65
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Kinin receptors in pain and inflammation
|European Journal of Pharmacology|2001|465
Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms <sup>1</sup>
|The FASEB Journal|1990|443
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization
|Trends in Pharmacological Sciences|1988|358